• Statistical Analysis Support to Expanding Clinical Services Portfolio

Laboratory Products

Statistical Analysis Support to Expanding Clinical Services Portfolio

Apr 07 2010

GxP Consulting announced the expansion of its GCP compliance and clinical technology support portfolio to include statistical analysis support for clinical data assessment. To accommodate the extended clinical technology support services and growing client base, GxP Consulting has also expanded its team of experts in this field. The new statistical analysis support service is led by newly appointed Timothy Haley, an experienced data analyst and SAS programmer. Timothy has an impressive background in data analysis, with previous posts held at Novartis, Glaxo Group Research plc, Wyeth Research (UK) Ltd, European Commission and Serono. He has also lectured at a number of European Universities, conducting research and publishing literature on this topic, demonstrating his wealth of knowledge.

The comprehensive clinical technology support services offered by GxP also include assistance with strategic outsourcing decisions. This ensures products progress through the clinical trials pipeline as quickly and cost-effectively as possible. GxP practically advises on the systems and technologies to best serve the needs of the clinical study, the optimal method of managing technologies and how to efficiently integrate multiple systems.The consulting team also assists with the management of vendor selection and subsequent management of suppliers, as well as ensuring that organisational structures are implemented to gain the right results from deployed technology. Other services include assistance with expansion planning and training and mentoring services to help clients achieve business objectives.

The consulting division has already achieved results for several world-leading clinical technology organisations responsible for the management of several hundred drug trials around the world annually. By altering aspects of the company structure and suggesting modifications to business processes, GxP was able to generate significant time and cost savings in the product development cycles, whilst maintaining compliance standards. GxP Consulting provides high-value, results-focused regulatory compliance services to the highly regulated pharmaceutical and biopharmaceutical industries.


Digital Edition

ILM 49.5 July

July 2024

Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...

View all digital editions

Events

ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia

Miconex

Jul 31 2024 Chengdu, China

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA

EMC2024

Aug 25 2024 Copenhagen, Denmark

View all events